These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1647193)

  • 1. Effects of granisetron and lorazepam, alone and in combination, on psychometric performance.
    Leigh TJ; Link CG; Fell GL
    Br J Clin Pharmacol; 1991 Mar; 31(3):333-6. PubMed ID: 1647193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of granisetron and haloperidol, alone and in combination, on psychometric performance and the EEG.
    Leigh TJ; Link CG; Fell GL
    Br J Clin Pharmacol; 1992 Jul; 34(1):65-70. PubMed ID: 1321654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of granisetron and lorazepam, alone and in combination, on the EEG of human volunteers.
    Link CG; Leigh TJ; Fell GL
    Br J Clin Pharmacol; 1991 Jan; 31(1):93-7. PubMed ID: 1849732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of BRL 46470A, a novel 5-HT3 receptor antagonist, and lorazepam on psychometric performance and the EEG.
    Link CG; Leigh TJ; Dennison JK
    Br J Clin Pharmacol; 1993 Apr; 35(4):395-9. PubMed ID: 8485019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects.
    O'Neill WM; Hanks GW; White L; Simpson P; Wesnes K
    Eur J Clin Pharmacol; 1995; 48(6):447-53. PubMed ID: 8582462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects.
    Hanks GW; O'Neill WM; Simpson P; Wesnes K
    Eur J Clin Pharmacol; 1995; 48(6):455-60. PubMed ID: 8582463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
    Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
    Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly.
    Kerr JS; Fairweather DB; Mahendran R; Hindmarch I
    Int Clin Psychopharmacol; 1992 Nov; 7(2):101-8. PubMed ID: 1487621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo.
    O'Neill WM; Hanks GW; Simpson P; Fallon MT; Jenkins E; Wesnes K
    Pain; 2000 Mar; 85(1-2):209-15. PubMed ID: 10692620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxprenolol plus ethanol causes no central nervous system depression--a comparison with lorazepam plus ethanol.
    Aucamp AK; Weis OF; Müller FO; Gill CE; Malan J
    S Afr Med J; 1984 Sep; 66(12):445-6. PubMed ID: 6385309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single oral doses of clobazam, diazepam and lorazepam on performance tasks and memory.
    Patat A; Klein MJ; Hucher M
    Eur J Clin Pharmacol; 1987; 32(5):461-6. PubMed ID: 2887431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep.
    Subhan Z; Harrison C; Hindmarch I
    Eur J Clin Pharmacol; 1986; 29(6):709-12. PubMed ID: 3709614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low doses of lorazepam on psychometric tests in healthy volunteers.
    Bourin M; Couëtoux du Tertre A; Colombel MC; Auget JL
    Int Clin Psychopharmacol; 1994; 9(2):83-8. PubMed ID: 8056998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: results of a placebo-controlled study in healthy volunteers.
    Mercer AJ; Lamb RJ; Rolan PE; Gibbens M; Posner J
    Psychopharmacology (Berl); 1998 Dec; 140(4):398-404. PubMed ID: 9888613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.
    Patat A; Perault MC; Vandel B; Ulliac N; Zieleniuk I; Rosenzweig P
    Br J Clin Pharmacol; 1995 Jan; 39(1):31-8. PubMed ID: 7756096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective and subjective assessments of the effects of flupentixol and benzodiazepines on human psychomotor performance.
    Mattila MJ; Mattila M; Aranko K
    Psychopharmacology (Berl); 1988; 95(3):323-8. PubMed ID: 2901125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.
    Upward JW; Arnold BD; Link C; Pierce DM; Allen A; Tasker TC
    Eur J Cancer; 1990; 26 Suppl 1():S12-5. PubMed ID: 2169778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers.
    Ferrara SD; Giorgetti R; Zancaner S; Orlando R; Tagliabracci A; Cavarzeran F; Palatini P
    Eur J Clin Pharmacol; 1999 Jan; 54(11):821-7. PubMed ID: 10027654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.
    García-Gea C; Ballester MR; Martínez J; Antonijoan RM; Donado E; Izquierdo I; Barbanoj MJ
    Br J Clin Pharmacol; 2010 Jun; 69(6):663-74. PubMed ID: 20565458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.